DK0749446T3 - Stærkt reaktive estere af carboxypolysaccharider og hidtil ukendte carboxypolysaccharider afledt deraf - Google Patents
Stærkt reaktive estere af carboxypolysaccharider og hidtil ukendte carboxypolysaccharider afledt derafInfo
- Publication number
- DK0749446T3 DK0749446T3 DK95913099T DK95913099T DK0749446T3 DK 0749446 T3 DK0749446 T3 DK 0749446T3 DK 95913099 T DK95913099 T DK 95913099T DK 95913099 T DK95913099 T DK 95913099T DK 0749446 T3 DK0749446 T3 DK 0749446T3
- Authority
- DK
- Denmark
- Prior art keywords
- carboxypolysaccharides
- polysaccharides
- carboxy
- pct
- modified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1994PD000043A IT1268955B1 (it) | 1994-03-11 | 1994-03-11 | Esteri attivi di polisaccaridi carbossilici |
PCT/EP1995/000932 WO1995024429A1 (fr) | 1994-03-11 | 1995-03-13 | Esters hautement reactifs de carboxy polysaccharides et nouveaux carboxy polysaccharides derives de ceux-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0749446T3 true DK0749446T3 (da) | 2000-05-08 |
Family
ID=11390595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95913099T DK0749446T3 (da) | 1994-03-11 | 1995-03-13 | Stærkt reaktive estere af carboxypolysaccharider og hidtil ukendte carboxypolysaccharider afledt deraf |
Country Status (11)
Country | Link |
---|---|
US (1) | US5856299A (fr) |
EP (1) | EP0749446B1 (fr) |
AT (1) | ATE186916T1 (fr) |
CA (1) | CA2184899C (fr) |
DE (1) | DE69513507T2 (fr) |
DK (1) | DK0749446T3 (fr) |
ES (1) | ES2141925T3 (fr) |
GR (1) | GR3032589T3 (fr) |
IT (1) | IT1268955B1 (fr) |
PT (1) | PT749446E (fr) |
WO (1) | WO1995024429A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1247472B (it) * | 1991-05-31 | 1994-12-17 | Fidia Spa | Processo per la preparazione di microsfere contenenti componenti biologicamente attivi. |
IT1287698B1 (it) * | 1996-08-29 | 1998-08-18 | Fidia Advanced Biopolymers Srl | Fili da sutura essenzialmente costituiti da derivati esterei dello acido ialuronico |
US6632802B2 (en) * | 1996-08-29 | 2003-10-14 | Fidia Advanced Biopolymers S.R.L. | Hyaluronic acid esters, threads and biomaterials containing them, and their use in surgery |
EP1806367A3 (fr) * | 1996-09-19 | 2007-11-28 | The Regents Of The University Of Michigan | Polymères contenant des polysaccharides tels que les alginates ou les alginates modifiés |
AU733716B2 (en) * | 1996-09-19 | 2001-05-24 | Regents Of The University Of Michigan, The | Polymers containing polysaccharides such as alginates or modified alginates |
ITPD980169A1 (it) * | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
IT1301994B1 (it) | 1998-08-05 | 2000-07-20 | Jasper Ltd Liability Co | Derivati dell'acido ialuronico. |
US6630457B1 (en) * | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
US6596126B1 (en) * | 1999-01-25 | 2003-07-22 | Kimberly-Clark Worldwide, Inc. | Modified polysaccharides containing aliphatic hydrocarbon moieties |
US6896769B2 (en) | 1999-01-25 | 2005-05-24 | Kimberly-Clark Worldwide, Inc. | Modified condensation polymers containing azetidinium groups in conjunction with amphiphilic hydrocarbon moieties |
US6517678B1 (en) | 2000-01-20 | 2003-02-11 | Kimberly-Clark Worldwide, Inc. | Modified polysaccharides containing amphiphillic hydrocarbon moieties |
US6398911B1 (en) | 2000-01-21 | 2002-06-04 | Kimberly-Clark Worldwide, Inc. | Modified polysaccharides containing polysiloxane moieties |
US6465602B2 (en) | 2000-01-20 | 2002-10-15 | Kimberly-Clark Worldwide, Inc. | Modified condensation polymers having azetidinium groups and containing polysiloxane moieties |
IT1317091B1 (it) * | 2000-02-08 | 2003-05-26 | S F I R Societa Fondaria Ind R | Gel di acido ialuronico cross-linked con l-amminoacidi ol-amminoesteri bifunzionali. |
US20030049253A1 (en) * | 2001-08-08 | 2003-03-13 | Li Frank Q. | Polymeric conjugates for delivery of MHC-recognized epitopes via peptide vaccines |
AU2003294318A1 (en) * | 2002-11-15 | 2004-06-15 | Arizona Board Of Regents Arizona State University | Therapeutic bioconjugates |
WO2004081055A1 (fr) | 2003-02-21 | 2004-09-23 | Terumo Kabushiki Kaisha | Derive de polysaccharide reticulable, procede pour le produire, composition de polysaccharide reticulable et substance de traitement medical |
US20050095219A1 (en) * | 2003-10-29 | 2005-05-05 | Shu-Ping Yang | Compositions for promoting vaginal cell proliferation and maturation |
US8313765B2 (en) | 2003-12-04 | 2012-11-20 | Industrial Technology Research Institute | Biodegradable hyaluronic acid derivative, biodegradable polymeric micelle composition and pharmaceutical or bioactive composition |
GB2408741B (en) * | 2003-12-04 | 2008-06-18 | Ind Tech Res Inst | Hyaluronic acid derivative with urethane linkage |
ITMI20041373A1 (it) | 2004-07-09 | 2004-10-09 | Lima Lto S P A | N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido |
ITPD20050056A1 (it) | 2005-03-02 | 2006-09-03 | Fidia Farmaceutici | Derivati ammidici del'acido ialuronico in osteoartrosi |
WO2008081463A2 (fr) * | 2007-01-04 | 2008-07-10 | Hepacore Ltd. | Dérivés réactifs solubles dans l'eau de carboxy polysaccharides et conjugués à base de carboxy polysaccharides et du fibrinogène |
EP2269665B1 (fr) * | 2008-05-01 | 2017-05-17 | Terumo Kabushiki Kaisha | Matériau de traitement médical visible |
ITMI20080981A1 (it) * | 2008-05-27 | 2009-11-28 | Fidia Advanced Biopolymers Srl | Processo per la preparazione di microsfere di polimeri semi-sintetici |
ITRM20080636A1 (it) | 2008-11-28 | 2010-05-29 | Univ Palermo | Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli. |
JP5604072B2 (ja) * | 2009-09-28 | 2014-10-08 | テルモ株式会社 | 活性エステル化多糖およびその製造方法 |
FR2966248B1 (fr) * | 2010-10-18 | 2020-05-01 | Centre National De La Recherche Scientifique (Cnrs) | Procede de fonctionnalisation de surfaces pour la detection d'analytes |
WO2012140650A2 (fr) | 2011-04-12 | 2012-10-18 | Hepacore Ltd. | Conjugués de carboxy polysaccharides avec des facteurs de croissance des fibroblastes et variants de ceux-ci |
TWI561535B (en) | 2011-10-06 | 2016-12-11 | Bvw Holding Ag | Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption |
FR3066386B1 (fr) * | 2017-05-18 | 2020-08-28 | Bioxis Pharmaceuticals | Procede de preparation d'un gel aqueux d'acide hyaluronique |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2881161A (en) * | 1955-03-25 | 1959-04-07 | Henkel & Cie Gmbh | Amides of alginic acid |
DD121785A1 (fr) * | 1975-08-06 | 1976-08-20 | ||
US4732863A (en) * | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
US5202431A (en) * | 1985-07-08 | 1993-04-13 | Fidia, S.P.A. | Partial esters of hyaluronic acid |
IT1203814B (it) * | 1986-06-30 | 1989-02-23 | Fidia Farmaceutici | Esteri dell'acido alginico |
US6174999B1 (en) * | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
IT1219942B (it) * | 1988-05-13 | 1990-05-24 | Fidia Farmaceutici | Esteri polisaccaridici |
IT1219587B (it) * | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
EP0518710B1 (fr) * | 1991-02-11 | 1996-05-22 | FIDIA S.p.A. | Esters de gellan |
-
1994
- 1994-03-11 IT IT1994PD000043A patent/IT1268955B1/it active IP Right Grant
-
1995
- 1995-03-13 WO PCT/EP1995/000932 patent/WO1995024429A1/fr active IP Right Grant
- 1995-03-13 DE DE69513507T patent/DE69513507T2/de not_active Expired - Lifetime
- 1995-03-13 ES ES95913099T patent/ES2141925T3/es not_active Expired - Lifetime
- 1995-03-13 AT AT95913099T patent/ATE186916T1/de not_active IP Right Cessation
- 1995-03-13 CA CA002184899A patent/CA2184899C/fr not_active Expired - Lifetime
- 1995-03-13 PT PT95913099T patent/PT749446E/pt unknown
- 1995-03-13 US US08/702,673 patent/US5856299A/en not_active Expired - Lifetime
- 1995-03-13 EP EP95913099A patent/EP0749446B1/fr not_active Expired - Lifetime
- 1995-03-13 DK DK95913099T patent/DK0749446T3/da active
-
2000
- 2000-02-04 GR GR20000400284T patent/GR3032589T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT749446E (pt) | 2000-05-31 |
CA2184899A1 (fr) | 1995-08-14 |
GR3032589T3 (en) | 2000-05-31 |
CA2184899C (fr) | 2006-05-30 |
DE69513507D1 (de) | 1999-12-30 |
EP0749446A1 (fr) | 1996-12-27 |
IT1268955B1 (it) | 1997-03-18 |
EP0749446B1 (fr) | 1999-11-24 |
ATE186916T1 (de) | 1999-12-15 |
US5856299A (en) | 1999-01-05 |
DE69513507T2 (de) | 2000-07-06 |
WO1995024429A1 (fr) | 1995-09-14 |
ITPD940043A1 (it) | 1995-09-11 |
ES2141925T3 (es) | 2000-04-01 |
ITPD940043A0 (it) | 1994-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0749446T3 (da) | Stærkt reaktive estere af carboxypolysaccharider og hidtil ukendte carboxypolysaccharider afledt deraf | |
HU9501953D0 (en) | Pharmaceutically active pyridine derivatives and process for the preparation thereof | |
AU5647996A (en) | Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives | |
CA2088343A1 (fr) | Solution stable de fibrinogene | |
EG20001A (en) | Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use | |
PT781281E (pt) | Derivados de beta-carbolina agonistas da melatonina seu processo de preparacao e sua utilizacao a titulo de medicamento | |
ATE213164T1 (de) | Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids | |
MX9501848A (es) | Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos. | |
FI946073A0 (fi) | Vitamiini D-sarjan, 20-asemassa modifioituja johdannaisia, menetelmä tällaisten johdannaisten valmistamiseksi, menetelmässä käytettäviä välituotteita, mainittuja johdannaisia sisältäviä farmaseuttisia valmisteita ja johdannaisten käyttö lääkeaineiden valmistamiseen | |
DE69309492D1 (de) | Antipyretische und analgetische zusammensetzungen, die optisch reines r-ketorolac enthalten | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
HU9201258D0 (en) | Process for the production of medical preparations for treating hiv infections and of their active agents | |
DE59511017D1 (de) | [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE | |
CA2215470A1 (fr) | Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations | |
ATE162804T1 (de) | Selbstvernetztes gellangummi | |
ATE172117T1 (de) | Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten | |
NO172043C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater | |
ATE162076T1 (de) | Verwendung von nadh und nadph zur herstellung eines arzneimittels zur behandlung von morbus alzheimer | |
BR9708297A (pt) | Compostos composição farmacéutica cosmposição e uso de uma composição cosmética | |
ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
AU4872797A (en) | Novel biaromatic dibenzofuran derivatives and their use in human or veterinary medicine and in cosmetics | |
RU94000064A (ru) | Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции | |
FR2658190B1 (fr) | Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant. | |
ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
DE3881484D1 (de) | Optisch aktive produkte von 20,21-dinoreburnamenin-derivaten, verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. |